HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Abdelilah S Gounni Selected Research

Semaphorins (Semaphorin)

1/2022PlexinD1 Deficiency in Lung Interstitial Macrophages Exacerbates House Dust Mite-Induced Allergic Asthma.
1/2021Semaphorin 3E Protects against Chlamydial Infection by Modulating Dendritic Cell Functions.
1/2021Semaphorin 3E Promotes Susceptibility to Leishmania major Infection in Mice by Suppressing CD4+ Th1 Cell Response.
1/2020Semaphorin 3E Regulates the Response of Macrophages to Lipopolysaccharide-Induced Systemic Inflammation.
1/2019Semaphorin 3E Inhibits House Dust Mite-Induced Angiogenesis in a Mouse Model of Allergic Asthma.
1/2019Genetic Deletion of Semaphorin 3E Aggravates Airway Contraction in a Mouse Model of Allergic Asthma.
1/2019The regulatory role of semaphorin 3E in allergic asthma.
1/2019Semaphorin 3E regulates apoptosis in the intestinal epithelium during the development of colitis.
1/2018Semaphorins and Their Roles in Airway Biology: Potential as Therapeutic Targets.
11/2017Downregulation of semaphorin 3E promotes hallmarks of experimental chronic allergic asthma.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Abdelilah S Gounni Research Topics

Disease

20Asthma (Bronchial Asthma)
01/2022 - 04/2008
19Inflammation (Inflammations)
12/2021 - 07/2009
6Respiratory Hypersensitivity
01/2022 - 03/2009
4Infections
12/2021 - 02/2016
3Hyperplasia
01/2022 - 07/2017
2Airway Remodeling
01/2018 - 10/2013
2Hypersensitivity (Allergy)
01/2013 - 07/2009
1Respiratory Syncytial Virus Infections
12/2021
1Colitis
01/2019
1Neuroinflammatory Diseases
02/2018
1Spinal Cord Injuries (Spinal Cord Injury)
02/2018
1Neoplasms (Cancer)
01/2018
1Sepsis (Septicemia)
01/2017
1Shock
01/2017
1Chronic Disease (Chronic Diseases)
01/2015
1Hypertrophy
01/2014
1Necrosis
10/2013
1Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
10/2013
1Autoimmune Diseases (Autoimmune Disease)
10/2013
1Atopic Dermatitis (Atopic Eczema)
06/2010
1Chronic Obstructive Pulmonary Disease (COPD)
06/2010

Drug/Important Bio-Agent (IBA)

12Semaphorins (Semaphorin)IBA
01/2022 - 01/2017
9CytokinesIBA
01/2022 - 07/2009
5Immunoglobulin E (IgE)IBA
01/2022 - 04/2008
4AllergensIBA
01/2022 - 01/2017
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2019 - 02/2013
3PTX3 proteinIBA
03/2017 - 01/2012
3Thymic Stromal LymphopoietinIBA
01/2013 - 04/2010
2Interleukin-10 (Interleukin 10)IBA
01/2022 - 02/2016
2InterleukinsIBA
01/2018 - 06/2009
2CollagenIBA
07/2017 - 01/2017
2Interleukin-17 (Interleukin 17)IBA
06/2014 - 03/2009
2IgE Receptors (Fc epsilon RI)IBA
07/2009 - 04/2008
1Chemokine CCL11IBA
12/2021
1Antiviral Agents (Antivirals)IBA
12/2021
1OvalbuminIBA
01/2021
1LipopolysaccharidesIBA
01/2020
1GlucocorticoidsIBA
01/2019
1Neuregulin-1 (Neuregulin 1)IBA
02/2018
1NeuropilinsIBA
01/2018
1Eosine Yellowish-(YS) (Eosin)IBA
03/2017
1Periodic AcidIBA
03/2017
1Hematoxylin (Haematoxylon)IBA
03/2017
1Protein Isoforms (Isoforms)IBA
01/2017
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
01/2017
1Interleukin-6 (Interleukin 6)IBA
02/2016
1Transforming Growth Factors (Transforming Growth Factor)IBA
02/2016
1Interleukin-2 (IL2)IBA
02/2016
1Interleukin-22 (IL-22)IBA
06/2014
1Contractile ProteinsIBA
01/2014
1Myosin-Light-Chain KinaseIBA
01/2014
1Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
10/2013
1CathelicidinsIBA
10/2013
1Antimicrobial PeptidesIBA
10/2013
1Neurotransmitter Agents (Neurotransmitter)IBA
02/2013
1LeptinIBA
01/2013
1Pattern Recognition ReceptorsIBA
01/2012
1Adrenal Cortex Hormones (Corticosteroids)IBA
04/2011
1ChemokinesIBA
06/2010
1Biological ProductsIBA
04/2008

Therapy/Procedure

2Therapeutics
01/2021 - 01/2019
1Immunotherapy
02/2018
1Intranasal Administration
07/2017